Minerva Neurosciences, Inc. (NASDAQ:NERV) reached 34.35% versus a 1-year low price of $4.80. The stock was last seen 8.4% higher, reaching at $6.45 on 03/13/2018. At recent session, the prices were hovering between $6 and $6.6. This company shares are 148.06% off its target price of $16 and the current market capitalization stands at $240.97M. The recent change has given its price a 9.26% lead over SMA 50 and -42.15% deficit over its 52-week high. The stock witnessed 16.22% gains, 13.16% gains and -5.84% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found NERV’s volatility during a week at 8.66% and during a month it has been found around 7.35%.Minerva Neurosciences, Inc. (NERV) Top Holders
Institutional investors currently hold around $163 million or 89.8% in NERV stock. Look at its top three institutional owners. Federated Investors Inc /Pa/ owns $44.84 million in Minerva Neurosciences, Inc., which represents roughly 18.61% of the company’s market cap and approximately 27.51% of the institutional ownership. Similar statistics are true for the second largest owner, Fmr Llc, which owns 4,679,744 shares of the stock are valued at $27.84 million. The third largest holder is Highland Capital Management Lp, which currently holds $12.86 million worth of this stock and that ownership represents nearly 5.33% of its market capitalization.
At the end of 12/31/2017 reporting period, 32 institutional holders increased their position in Minerva Neurosciences, Inc. (NASDAQ:NERV) by some 1,245,354 shares, 33 decreased positions by 2,353,367 and 16 held positions by 23,806,375. That puts total institutional holdings at 27,405,096 shares, according to SEC filings. The stock grabbed 11 new institutional investments totaling 367,996 shares while 14 institutional investors sold out their entire positions totaling 1,011,422 shares.Minerva Neurosciences, Inc. (NASDAQ:NERV) Insider Trades
Multiple company employees have indulged in significant insider trading. Minerva Neurosciences, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that EVP, CFO & CBO Race Geoff has sold 5,829 shares of Minerva Neurosciences, Inc. (NERV) in trading session dated Dec. 14, 2017. These shares are worth $33,750 and were traded at $5.79 each. The SEC filing shows that Ahlholm Frederick W performed a sale of 1,661 shares. The SVP, Chief Accounting Officer disposed these shares by way of transaction on Dec. 14, 2017. The company’s shares were given away at $5.8 per share worth to an income of some $9,634 on account of Ahlholm Frederick W.
SVP & COO, Reilly Joseph H., sold 2,906 common shares of Minerva Neurosciences, Inc. (NERV) in the open market. In a transaction dated Dec. 14, 2017, the shares were put up for sale at an average price of $5.8, raking in a sum of $16,855. After this sale, 14,177 common shares of NERV are directly owned by the insider, with total stake valued at $91,442.
In the transaction dated Dec. 14, 2017, the great number of shares disposed came courtesy the CEO; Luthringer Remy disposed a total of 2,194 shares at an average price of $5.85, amounting to approximately $12,835. The insider now directly owns 943,160 shares worth $6,083,382.Minerva Neurosciences, Inc. (NERV) Analyst Guide
Not many analysts have released their opinion on Minerva Neurosciences, Inc. (NASDAQ:NERV), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.